FDA approval confirms that ExAblate® MRI-guided Focused Ultrasound is effective in reducing pain from bone metastases in patients who could not undergo radiation therapy.
pain management
510(k) Clearance For NeuroMetrix SENSUS™ Pain Management Device
NeuroMetrix, Inc., a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, announced that it has received 510(k) clearance for its SENSUS™ Pain Management device from the U.S FDA.
Medical Device Alert: GEMSTAR™ Bolus Cord For Use With GEMSTAR™ Infusion Pump
UK MHRA has issued a Medical Device Alert (MDA) pertaining to the GEMSTAR™ infusion pump manufactured by Hospira Inc. It seems the accessory Bolus Cord can become damaged and consequently fail to deliver requested medication to the patient.
Smiths Medical Launches New Ambulatory Pain Management System
Smiths Medical’s new version of its CADD®-Solis system now combines PCA and Programmed Intermittent Bolus (PIB) deliveries to labour analgesia and post-operative pain management.
Implantable, Programmable Drug Pump Gains FDA Clearance
The Prometra implantable, programmable pump from Medasys, represents the first non-peristaltic drug-infusion device to gain PMA approval. The product is already CE marked and available in selected European countries, with full EU roll-out expected in the next few months.